Cardiovascular companies develop diagnostics, therapies and research technologies for diseases affecting the heart and circulatory system. Their work supports earlier detection, improved disease management and the development of new treatments for cardiovascular conditions.
This category includes companies working on:
Browse 71 UK cardiovascular companies below.
Contract development and manufacture of nanofibrous biomaterials for medical devices
The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using electrospinning technology, the company produces four proprietary membrane platforms: resorbable Mimetix, permanent Kalyptix, biosynthetic Symatix, and…
Antibody therapy to deplete amyloid deposits in ATTR cardiomyopathy
Immutrin is a biotechnology company developing an engineered antibody therapeutic designed to actively remove amyloid deposits from tissues in patients with amyloidosis. Its lead asset targets ATTR cardiomyopathy, a progressive and often fatal cardiac disease caused by transthyretin amyloid accumulation, for which no…
Microscopy and imaging systems for developmental and cardiovascular research
Indigo Scientific is a UK manufacturer and supplier of optical and microscopy imaging systems for life science research. The company's High-Resolution Episcopic Microscopy systems generate detailed 3D reconstructions of biological samples such as mouse embryos and hearts through serial block-face imaging, widely used…
European hub for RNAi therapeutics developer
Alnylam UK is the European operational headquarters of Alnylam Pharmaceuticals, the pioneer of RNA interference therapeutics. Based in Maidenhead, the UK office serves as Alnylam's primary base for European commercial operations, medical affairs, and regulatory activities. Alnylam has six approved RNAi medicines on…
AI-driven combinatorial analytics platform for chronic disease biology
PrecisionLife is a computational biology company applying AI-driven combinatorial analytics to complex chronic diseases. Its platform identifies causal biological mechanisms and patient subgroups at a resolution not achievable by conventional genomic methods, enabling novel drug target discovery, patient…
Cardiac protein antibodies and S-palmitoylation research reagents
Badrilla is a supplier of research reagents for life science laboratories, specialising in antibodies against cardiac proteins involved in calcium handling and contraction, many of which detect specific phosphorylation states. It also offers kits and reagents for studying protein S-palmitoylation, a reversible lipid…
AI-driven precision therapeutics for metabolic syndrome diseases
Multiomic Health is a data-centric therapeutics company developing precision medicines for metabolic syndrome-related conditions, including type 2 diabetes, cardiovascular disease, chronic kidney disease and non-alcoholic fatty liver disease. The company integrates multi-omics data with longitudinal clinical datasets…
Reprogrammed stem cell therapies for vascular disease and chronic wounds
ReproGo is a Belfast-based regenerative medicine company developing Advanced Therapy Medicinal Products through direct cell reprogramming of adult cells into vascular lineages. The company's manufacturing approach produces stem cell-derived vascular cells and organoids through a xeno-free, low-dose process designed…
AI-enabled personalised dosing for drug-digital combination therapies
Closed Loop Medicine develops combination products integrating pharmaceutical therapies with AI-powered digital companions to personalise drug dosing for chronic conditions. Its platform applies pharmacometric modelling and patient response data to optimise treatment regimens. The pipeline includes co-packaged drug…
AI-designed extended-expression RNA therapeutics for cardio-metabolic disease
ScionxBio, formerly Eleven Therapeutics, is a biotechnology company developing xRNA, a chemically expanded RNA modality engineered to extend protein expression from days to months. Combinatorial chemistry and deep learning are combined to design molecules with enhanced stability and reduced immune sensing, enabling…
High-purity blood coagulation enzymes and antibodies for research
Enzyme Research Laboratories is a Swansea-based manufacturer and supplier of high-purity coagulation reagents for haemostasis and thrombosis research. Its product range covers purified zymogens and activated enzymes derived from human and bovine plasma, alongside monoclonal and polyclonal antibodies against…
AI-generated virtual patients for medical device testing
adsilico is a University of Leeds spin-out developing computational models for preclinical medical device research. It combines generative AI with anonymised clinical imaging to create synthetic patient anatomies, then uses physics-based simulations to investigate how implantable devices perform across diverse…
AI imaging platform for lung and heart disease clinical trials
Qureight is a technology-driven imaging contract research organisation providing clinical data curation and AI-powered image analysis services to pharmaceutical and biotech companies. Its proprietary platform integrates CT imaging, biomarkers, and clinical metadata from complex respiratory and cardiovascular diseases,…
Nanotechnology-based point-of-care cardiovascular diagnostics for decentralised healthcare
The NanoBioTechnology Hub is a Manchester-based developer of miniaturised point-of-care diagnostic devices using nanotechnology and biotechnology. The company is developing an ultra-sensitive handheld device for pre-hospital cardiovascular biomarker analysis, using lateral flow technology and biointerfaced…
Global pharmaceutical company developing medicines across major disease areas
AstraZeneca is a multinational biopharmaceutical company engaged in the research, development, manufacture, and commercialisation of prescription medicines. Its pipeline and product portfolio span oncology, cardiovascular and metabolic disease, respiratory and immunology, rare diseases, and vaccines. The company…
Handheld blood-electrolyte monitoring technology for kidney and cardiovascular care
Kalium Health is a medical technology company developing handheld blood-electrolyte monitoring for people with kidney and cardiovascular conditions. Its device is designed to measure potassium and other electrolytes from a single drop of blood using disposable test consumables, supporting monitoring outside…
Human cardiomyocyte assays for cardiac safety pharmacology
Clyde Biosciences is a contract research organisation specialising in human cardiomyocyte assays for cardiac drug safety and efficacy. Its optical platform measures membrane voltage, calcium dynamics and contraction in induced pluripotent stem cell-derived cardiomyocytes within a single experiment, generating…
AI-driven protein interaction modelling for peptide drug discovery
Xenos Bio is developing a computational platform that uses physics-based algorithms integrated with machine learning to predict protein-protein interactions and identify binding motifs within functional protein domains. Its software is deployed for rational peptide library construction, delivering enhanced hit…
Biologic therapies for autoinflammatory and autoimmune diseases
Kiniksa Pharmaceuticals International is a commercial-stage biopharmaceutical company focused on acquiring, developing and commercialising medicines for autoinflammatory and autoimmune diseases with significant unmet need. Its approved product, rilonacept, is an IL-1 inhibitor indicated for recurrent pericarditis. The…
AI-driven mass spectrometry biomarker services for diagnostics and drug development
Guilford Street Laboratories Ltd is a contract research organisation providing machine learning-powered mass spectrometry services for biomarker discovery, assay development, and precision medicine. The company specialises in high-sensitivity multi-omic analysis of protein, lipid, and metabolite biomarkers, supporting…